Funding round-up: AAVantgarde, Cellusion, Santero, iCellate Medical

Sweden: iCellate Medical, a privately held life sciences company, has closed a SEK20m (US$1.9m) funding round from a combination of existing and new investors, the management team and board members. iCellate develops cancer tests for early detection, treatment selection, and hereditary cancer risk. “It has been tougher than ever to raise capital given the current…

You must be a HMI Subscriber to view this content.

Subscribe Now »